Prohormone convertase 1/3 deficiency causes obesity due to impaired proinsulin processing

Nat Commun. 2022 Aug 13;13(1):4761. doi: 10.1038/s41467-022-32509-4.

Abstract

Defective insulin processing is associated with obesity and diabetes. Prohormone convertase 1/3 (PC1/3) is an endopeptidase required for the processing of neurotransmitters and hormones. PC1/3 deficiency and genome-wide association studies relate PC1/3 with early onset obesity. Here, we find that deletion of PC1/3 in obesity-related neuronal cells expressing proopiomelanocortin mildly and transiently change body weight and fail to produce a phenotype when targeted to Agouti-related peptide- or nestin-expressing tissues. In contrast, pancreatic β cell-specific PC1/3 ablation induces hyperphagia with consecutive obesity despite uncontrolled diabetes with glucosuria. Obesity develops not due to impaired pro-islet amyloid polypeptide processing but due to impaired insulin maturation. Proinsulin crosses the blood-brain-barrier but does not induce central satiety. Accordingly, insulin therapy prevents hyperphagia. Further, islet PC1/3 expression levels negatively correlate with body mass index in humans. In this work, we show that impaired PC1/3-mediated proinsulin processing, as observed in human prediabetes, promotes hyperphagic obesity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Diabetes Mellitus*
  • Genome-Wide Association Study
  • Humans
  • Hyperphagia / genetics
  • Insulin / metabolism
  • Obesity / complications
  • Obesity / genetics
  • Obesity / metabolism
  • Proinsulin* / genetics
  • Proinsulin* / metabolism
  • Proprotein Convertase 1 / genetics

Substances

  • Insulin
  • Proinsulin
  • Proprotein Convertase 1